Lipid microspheres (lipid emulsions) as a drug carrier - An overview

Advanced Drug Delivery Reviews

Volumn 20, Issue 2-3, 1996, Pages 113-115

  Mizushima, Yutaka ^a  

^a ST MARIANNA UNIVERSITY SCHOOL OF MEDICINE   (Japan)

Author keywords

Corticosteroid; Drug delivery system; Lipid emulsion; Lipid microsphere preparation; Lipid microspheres; Liposomes; Prostaglandin E1

Indexed keywords

DISEASES; DRUG DOSAGE; DRUG INFUSION; DRUG PRODUCTS; EMULSIONS; LIPIDS; PATIENT TREATMENT; PHARMACOKINETICS;

CORTICOSTEROID; DRUG CARRIER; DRUG DELIVERY SYSTEM; LIPID EMULSIONS; LIPID MICROSPHERE PREPARATION; LIPID MICROSPHERES; LIPOSOMES; PROSTAGLANDIN E;

DRUG THERAPY;

DRUG CARRIER; GLYCEROL; HYDROCORTISONE; INTRALIPID; LIPID EMULSION; LIPOSOME; MICROSPHERE; NONSTEROID ANTIINFLAMMATORY AGENT; OLEIC ACID; PHOSPHATIDYLCHOLINE; PHOSPHOLIPID; PROSTAGLANDIN E1; SOYBEAN OIL; STEROID;

DRUG ADMINISTRATION; DRUG DELIVERY SYSTEM; DRUG TARGETING; HUMAN; INFLAMMATORY DISEASE; JAPAN; NONHUMAN; PHARMACEUTICS; PRIORITY JOURNAL; SHORT SURVEY; TECHNOLOGY; TISSUE DISTRIBUTION;

EID: 0030602831     PISSN: 0169409X     EISSN: None     Source Type: Journal    
DOI: 10.1016/0169-409X(95)00114-M     Document Type: Review

References (11)

1. [1] Fendler, J.H. and Romero, A. (1977) Liposomes as drug carriers. Life Sci. 20, 1109-1120.
2. [2] Weinstein, J.N. (1984) Liposomes as drug carriers in cancer therapy, Cancer Treat. Rep. 68, 127-135.
3. [3] Gregoriadis, G. (1984) Liposome technology. In: Gregoriadis, G., Allison, A.C., (Eds.) Liposomes in Biological Systems, Vols. I-III, J. Wiley & Sons, New Jersey.
4. [4] Hallberg, D. (1965) Elimination of exogenous lipids from the bloodstream. Acta. Physiol. Scand. 65, Suppl. 254, 3-23.
5. [5] Koga, Y., Swanson, V.L. and Hayes, D.M. (1975) Hepatic "intravenous fat pigment" in infants and children receiving lipid emulsion. J. Pediatr. Surg. 10, 641-648.
6. [6] Philips, N.C., Thomas, D.P.P., Night, C.G. and Dingle, J.T. (1979) Liposome incorporated corticosteroids, II. Therapeutic activity in experimental arthritis. Ann. Rheum. Dis. 38, 553-557.
7. [7] De Silva, M., Hazleman, B.L., Thomas, D.P.P. and Wright, P. (1979) Liposomes in arthritis: a new approach. Lancet i, 1320-1322.
8. [8] Mizushima, Y., Hamano, T. and Yokoyama, K. (1982) Tissue distribution and anti-inflammatory activity of corticosteroids incorporated in lipid emulsion. Ann. Rheum. Dis. 41, 263-267.
9. [9] Yokoyama, K., Ueda, Y., Kikukawa, A. and Yamanouchi, K. (1990) Drug delivery systems: the industrial view. In: G. Gregoriadis (Ed.) Targeting of Drugs: Optimization Strategies, Plenum, New York (in press).
10. [10] Davis, S.S., Hadgraft, J. and Palin, K.J. (1985) Pharmaceutical emulsions, In: Becher, P., (Ed.) Encyclopedia of Emulsion Technology 3, Marcel Dekker, New York, p. 159.
11. [11] Shaw, I.H., Knight, C.G., Thomas, D.P.P., Philips, N.C. and Dingle, J.T. (1979) Liposome-incorporated corticosteroids: 1. The interaction of liposomal cortisol palmitate with inflammatory synovial membrane. Br. J. Exper. Pathol. 60, 142-150.